Please sign in to follow a disease.
Chronic asthma
MONDO:0850282An asthma that is characterized by the development of persistent airway inflammation and recurrent attacks of breathlessness and wheezing, which vary in severity and frequency.
Also known as: adult-onset severe asthma, persistent mild asthma, persistent moderate asthma, persistent severe asthma
156 clinical trials for this condition and its sub-types, 114 tagged with Chronic asthma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Chronic asthma
-
T2-high asthma 46 trials
-
Intermittent asthma 2 trials
-
T2-low asthma 1 trial
-
Extrinsic asthma 0 trials
-
Nocturnal asthma 0 trials
-
Could a smart lung monitor outsmart asthma symptoms?
Disease control Stopped earlyThis trial tests whether a personalized asthma action plan guided by a home monitoring device—using Forced Oscillation Technique (FOT) to measure lung function—can improve asthma control better than the usual approach of adjusting medication based on how symptoms feel. People age…
Sponsor: Restech Srl • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New asthma pill shows promise in early trial
Disease control Stopped earlyThis phase 2 study tested an experimental oral drug called RPT193 in 38 adults with moderate-to-severe asthma that was not fully controlled by standard inhalers. The goal was to see if RPT193 could reduce asthma attacks and improve lung function. The trial was terminated early, s…
Phase 2 • Sponsor: RAPT Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New asthma treatment for kids who Don't respond to standard steroids?
Disease control Stopped earlyThis study tested whether a drug called tiotropium works as well as inhaled steroids for children aged 6 to 11 with mild asthma that is not linked to allergies. Many children with non-allergic asthma do not respond well to steroids, so researchers wanted to see if tiotropium alon…
Phase 2 • Sponsor: Nemours Children's Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Asthma drug safety check: dexpramipexole under Long-Term review
Disease control Stopped earlyThis study looked at the long-term safety of dexpramipexole in adults with severe eosinophilic asthma. Participants had already completed earlier phase 3 trials. The goal was to track side effects and asthma control over time. However, the study was terminated early, which may li…
Phase 3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Asthma drug trial halted midway: what it means for patients
Disease control Stopped earlyThis study tested a daily pill called dexpramipexole in 654 people with severe eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. The goal was to see if the drug could reduce severe asthma attacks over a year. However, the trial was terminat…
Phase 3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Asthma drug trial halted: Dexpramipexole's promise unfulfilled
Disease control Stopped earlyThis Phase 3 trial tested dexpramipexole, an oral drug, in over 1,000 people with severe eosinophilic asthma that was not well controlled by standard treatments. The goal was to see if it could reduce severe asthma attacks over a year. However, the study was terminated early, so …
Phase 3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Tiny study on steroid bone damage fizzles out
Knowledge-focused Stopped earlyThis study aimed to see if special CT scans could detect changes in bone density and bone marrow in people with asthma who take oral steroids. Only 2 people took part before the study was stopped early. The results are too limited to draw any conclusions.
Sponsor: University of Iowa • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Body clock may predict asthma attacks
Knowledge-focused Stopped earlyThis study looked at whether proteins that control our body's daily rhythms (clock proteins) can predict how severe asthma will get. Researchers monitored these proteins in the blood and sputum of 50 adults with severe eosinophilic asthma before and during treatment with mepolizu…
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Asthma study aims to better understand uncontrolled disease in daily life
Knowledge-focused Stopped earlyThis study looked at adults with severe uncontrolled asthma in Germany to see how well their asthma was controlled over 12 months. Researchers used a simple questionnaire called AIRQ® to track symptoms, medication use, and doctor visits. The goal was to gather real-world informat…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:03 UTC